Drug Shortage Report for TEVA-GABAPENTIN

Last updated on 2021-02-11 History
Report ID 131694
Drug Identification Number 02247346
Brand name TEVA-GABAPENTIN
Common or Proper name GABAPENTIN 800MG TAB
Company Name TEVA CANADA LIMITED
Market Status MARKETED
Active Ingredient(s) GABAPENTIN
Strength(s) 800MG
Dosage form(s) TABLET
Route of administration ORAL ORAL
Packaging size 100
ATC code N03AX
ATC description ANTIEPILEPTICS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2021-01-13
Estimated end date 2021-02-28
Actual end date 2021-02-10
Shortage status Resolved
Updated date 2021-02-11
Company comments
Health Canada comments
Contact Address 30 NOVOPHARM COURT
TORONTO, ONTARIO
CANADA M1B 2K9
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v4 2021-02-11 French Compare
v3 2021-02-11 English Compare
v2 2021-01-15 French Compare
v1 2021-01-15 English Compare